Redshiftbio
Boxborough, US · Delaware corporation · 2 known investors
Redshift Bio develops real-time monitoring technology for biomolecular structure and concentration analysis in biopharmaceutical development and manufacturing. The platform enables pharmaceutical and biotech companies to make earlier decisions by providing direct structural insights during production processes.
Founders & leadership
TO
Thomas O'LenicExecutive Officer, Director
EM
Eugene MaExecutive Officer
CM
Charles MarshallExecutive Officer, Director
FS
Frank SmithDirector
WC
William CadoganDirector
BH
Bryson HollimonDirector
WM
Wouter MeulemanDirector
SH
Susan HolleranDirector
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$5.9MraisedJun 2025 · 8 investors · Other TechnologyRule 506(b)
▶$5.9MraisedJun 2025 · 8 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Frank SmithDirector
- William CadoganDirector
- Bryson HollimonDirector
- Susan HolleranDirector
- Wouter MeulemanDirector
- Thomas O'LenicExecutive Officer, Director
- Offering amount
- $7.1M
- Amount sold
- $5.9M
- First sale
- Jun 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5MraisedApr 2024 · 6 investors · Other TechnologyRule 506(b)
▶$5MraisedApr 2024 · 6 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Bryson HollimonDirector
- Mark CafazzoDirector
- William CadoganDirector
- Wouter MeulemanDirector
- Thomas O'LenicExecutive Officer, Director
- Frank SmithDirector
- Amol ChaubalDirector
- Offering amount
- $7M
- Amount sold
- $5M
- First sale
- Mar 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10MraisedOct 2021 · 12 investors · Other TechnologyRule 506(b)
▶$10MraisedOct 2021 · 12 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Charles PurtellDirector
- Julien BradleyExecutive Officer, Director
- Bryson HollimonDirector
- William CadoganDirector
- Frank SmithDirector
- Amol ChaubalDirector
- Offering amount
- $20M
- Amount sold
- $10M
- Sales commissions
- $275K
- Placement agents
- Bowen Advisors Inc.
- First sale
- Oct 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.4MraisedDec 2020 · 6 investors · Other TechnologyRule 506(b)
▶$6.4MraisedDec 2020 · 6 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Charles PurtellDirector
- William CadoganDirector
- Frank SmithDirector
- Julien BradleyExecutive Officer, Director
- Bryson HollimonDirector
- Rob CarsonDirector
- Offering amount
- $6.4M
- Amount sold
- $6.4M
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$18.3MraisedDec 2019 · 11 investors · Other TechnologyRule 506(b)
▶$18.3MraisedDec 2019 · 11 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- William CadoganDirector
- Charles MarshallExecutive Officer, Director
- Rob CarsonDirector
- Eugene MaExecutive Officer
- Bryson HollimanDirector
- Frank SmithDirector
- Offering amount
- $18.3M
- Amount sold
- $18.3M
- First sale
- Sep 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10.8MraisedMar 2017 · 10 investors · Other TechnologyRule 506(b)
▶$10.8MraisedMar 2017 · 10 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Eugene MaExecutive Officer
- Frank SmithDirector
- William CadoganDirector
- Bryson HollimanDirector
- Charles MarshallExecutive Officer, Director
- Offering amount
- $10.8M
- Amount sold
- $10.8M
- Sales commissions
- $250K
- Placement agents
- Bowen Advisors, Inc.
- First sale
- Feb 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$998.1KraisedOct 2015 · 4 investors · Other TechnologyRule 506(b)
▶$998.1KraisedOct 2015 · 4 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Frank SmithDirector
- Eugene MaExecutive Officer
- William CadoganDirector
- Charles MarshallExecutive Officer, Director
- Bryson HollimonDirector
- Offering amount
- $2M
- Amount sold
- $998.1K
- Minimum investment
- $1
- Proceeds to insiders
- $50.5K
- First sale
- Sep 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.